International Pharmaceutical Aerosol Consortium on Regulation & Science

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is an international association that seeks to advance the science, and especially the regulatory science, of orally inhaled and nasal drug products (OINDPs) by collecting and analyzing data, and conducting joint research and development projects. Representing the OINDP industry since 2000, IPAC-RS aims to build consensus and contribute to effective regulations and standards by sharing the results of its research through conferences, technical journals, webinars, and discussions with regulatory bodies.

News and Events

April 2020
​
The liability of fine particle dose (FPD) Can we rely on the fine partical dose metric alone for quality control?

 

April 2020
​
The IPAC-RS 2019 Year in Review (Annual Report) is now available.

 

April 26, 2020
​
Digital RDD 2020 and IPAC-RS Symposium- The Global Regulatory Landscape and Advances in Digital Technology: Transforming the OINDP-Patient Experience.

 

July 2020
​
Visit the IPAC-RS Pharmaceutical Aerosols Resource Center (PARC) to learn about science and regulation of medicinal aerosols and delivery systems – including those involved in addressing COVID-19.   Contact us with questions or suggestions.

 

 

Become an IPAC-RS member today!

Inquire below.

© 2020 IPAC-RS